article thumbnail

US Pharmacopeia Provides Resources for Compounding Pharmacies to Support Patient Safety Amid Drug Shortages

Pharmacy Times

Farah Towfic, PharmD, MBA, RPh, discusses how US Pharmacopeia helped to strengthen supply chain resilience in 2024 through data-driven insights, policy advocacy, and pharmacist engagement to address prolonged drug shortages, particularly for generic sterile injectables.

article thumbnail

The Stokes & Bova Partnership: Transforming Veterinary Medicine

epicur

In the Spring of 2024, the two organizations announced they were partnering to bring life-saving treatment for cats with feline infectious peritonitis (FIP) to the United States. Since the announcement and the availability of the treatment, GS-441524 , Stokes Pharmacy has successfully treated thousands of patients.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re reading about Novo and GLP-1 compounding, Paxlovid and long Covid, and more

STAT

Food and Drug Administration seeking to block compounding pharmacies in the U.S. We hope you have a meaningful and manageable day. Best of luck, and do keep in touch. … Novo Nordisk filed another citizen’s petition with the U.S. from making versions of one of its GLP-1 agonist drugs , Pharmaphorum notes.

article thumbnail

Blood Sugar, Hashimoto’s, Ozempic, Metformin and Berberine

The Thyroid Pharmacist

Compounding pharmacies will sometimes repackage these drugs, or create lower or different concentrations than what’s typically available. Treasure Island (FL): StatPearls Publishing; February 29, 2024 [17] Clinical Review Report: Semaglutide (Ozempic): (Novo Nordisk Canada Inc.): June 25, 2024. Epub 2018 May 14.